Multiple sclerosis (MS) is an inflammatory-mediated demyelinating disease of the human
central nervous system. The clinical disease course is variable, usually starts with reversible …

This article provides a comprehensive overview of the pathology of multiple sclerosis (MS),
including recent insights into its molecular neuropathology and immunology. It shows that all …

The focus of multiple sclerosis (MS) research has been on attempts to identify the specific
pathogenic mechanism responsible for producing the multifocal central nervous system …

The spectrum of multiple sclerosis: new lessons from patholo... : Current Opinion in
Neurology The spectrum of multiple sclerosis: new lessons from pathology : Current …

Multiple sclerosis (MS) is a chronic but incurable disease of the central nervous system
(CNS) that is often diagnosed in the second or third decade of life. It is more common among …

Major progress has been made during the past three decades in understanding the
inflammatory process and pathogenetic mechanisms in multiple sclerosis (MS) …

Multiple sclerosis (MS) is a multi‐component disease characterized by inflammation,
neurodegeneration and failure of central nervous system (CNS) repair mechanisms …

Multiple sclerosis (MS) is an inflammatory demyelinating disease of the CNS. Most MS
patients follow a relapsing-remitting course (RR-MS) for 8 to 15 years that transforms into a …

Multiple sclerosis (MS) is an autoimmune central nervous system (CNS) demyelinating
disease that causes relapsing and chronic neurologic impairment. Recent observations …

Multiple sclerosis (MS) is an autoimmune disease triggered by environmental factors that act
on a genetically susceptible host. It features three clinical stages: a pre-clinical stage …